Jennifer L. Vande-Voort
Child and Adolescent Psychiatry
1216 2nd St SW
Rochester,, MN 55902
Rochester,, MN 55902
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 101 publications
Metabolomic correlates of intravenous racemic ketamine in treatment-resistant major depressive disorder: the Bio-K/NNDC multicenter trial.
Journal: The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry
Published: September 06, 2026
Hepatic Safety of Ketamine and Esketamine for Treatment-Resistant Depression: A Real-World Cohort Study.
Journal: Journal of clinical psychopharmacology
Published: April 14, 2026
Early suicidal ideation change and suicidality-associated emergency department utilization after ketamine or esketamine treatment in treatment-resistant depression.
Journal: Therapeutic advances in psychopharmacology
Published: February 18, 2026
Next-Step Treatment Options for Treatment-Resistant Depression: Insights From the Mayo Clinic Depression Center Panel.
Journal: The Journal of clinical psychiatry
Published: January 28, 2026
Feasibility of Digital Augmentation of Parent-Child Interaction Therapy: A Randomized Clinical Trial.
Journal: JAMA network open
Published: December 15, 2025
Microbiome and Vocalization Biomarkers of Infant Distress, Maternal Depression and Parenting Styles.
Microbiome and Vocalization Biomarkers of Infant Distress, Maternal Depression and Parenting Styles.
Journal: Chronic stress (Thousand Oaks, Calif.)
Published: October 28, 2025
Ketamine Reduces Suicidality-Associated Emergency Department Utilization in Patients With Treatment-Resistant Depression: A 6-Month Mirror-Image Study.
Journal: The Journal of clinical psychiatry
Published: September 18, 2025
Long-Term Outcomes in Patients With Treatment-Refractory Depression Receiving Intravenous Ketamine and Intranasal Esketamine: An Observational Study.
Journal: The Journal of clinical psychiatry
Published: August 06, 2025
An examination of anhedonia as a predictor of response with transcranial magnetic stimulation treatment for youth with depression.
Journal: Journal of mood and anxiety disorders
Published: July 19, 2025
Intravenous ketamine versus esketamine for depression: a systematic review and meta-analysis.
Journal: Therapeutic advances in psychopharmacology
Published: July 10, 2025
Neurochemical and neurophysiological glutamatergic correlates in adolescents with depression: An exploratory ultra-high field magnetic resonance spectroscopy and transcranial magnetic stimulation study.
Journal: Journal of affective disorders
Published: June 05, 2025
A feasibility study of sequenced TMS and TBS dosing in adolescents with major depressive disorder.
Journal: Transcranial magnetic stimulation (2024)
Published: June 03, 2025
Last Updated: 09/26/2026